Friday, July 30, 2021
Johnson & Johnson to Pay $417 million in Ovarian Cancer Case
By City News Service
Published August 24, 2017

A Los Angeles jury Monday awarded $417 million to an ovarian cancer patient who alleged her disease was caused by the use of Johnson & Johnson talcum powder.

Eva Echeverria, 63, of Los Angeles, was among seven women who filed suit in Los Angeles Superior Court in July 2016, alleging that for years they used talcum powder sold by Imerys Talc America Inc. and Johnson & Johnson according to its instructions.


“We are grateful for the jury’s verdict on this matter and that Eva Echeverria was able to have her day in court,” said her attorney, Mark Robinson. “These cases are about fighting for justice for women all over California who are suffering from ovarian cancer because of Johnson & Johnson’s covering up the truth for so many years.”

New Brunswick, New Jersey-based Johnson & Johnson maintained that Echeverria’s allegations were not supported by scientific evidence. The company has lost four out of five similar trials over the past two years.

“We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder,”‘ Johnson & Johnson said in a statement.

Echeverria said she began using the talcum powder when she was 11 years old and did not stop until January 2016, when she saw a news story about another woman who also had ovarian cancer and had used the product. She was diagnosed with ovarian cancer in 2007, when doctors removed a softball-sized tumor.

She said she would have stopped using the powder if Johnson & Johnson had warned her about its dangers on the label.

The verdict following a four-week trial at the Central Civil West courthouse — consisting of $70 million in compensatory damages and $347 million in punitive damages — was the largest yet in lawsuits alleging Johnson & Johnson failed to adequately warn consumers about the cancer risks of its talc-based products and the first in California to go to trial.


Echeverria’s complaint stated that studies in 1971 and 1982 revealed a link between talc and ovarian cancer. Based on the studies and other allegations of later public health studies and other information, she alleged that the company was aware, or should have known, it was marketing a product harmful to women.

Categories: Health | National | News
Tags: | | | |

Get the Los Angeles Sentinel App!

Since 1933 The Voice of Our Community Speaking for Itself.
88 Years of LA Sentinel.
Black News.

LA Sentinel
in your pocket:


LA Watts Times

© 2021 Los Angeles Sentinel All Rights Reserved • A Bakewell Media Publication

AboutArchivesContact UsCorrections & MisprintsMedia Kit

Terms of ServicePrivacy Policy

LA Watts TimesTaste of Soul

Close / I'm already on the list

Subscribe Today!

Don't be limited anymore! Subscribe Now »

** Existing subscribers, please Login / Register for Digital »

Subscribe to The Los Angeles Sentinel for only $5.99 $3.99 per month, with 1 month free!

Relax in comfort each week as you read the printed newspaper on your own time, delivered weekly to your home or office. This subscription also includes UNLIMITED DIGITAL ACCESS for all of your devices. Includes FREE shipping! One easy payment of $3.99/month gets you:

Subscribe Now »